1. Home
  2. UPLD vs XGN Comparison

UPLD vs XGN Comparison

Compare UPLD & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$3.57

Market Cap

10.9M

Sector

Technology

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$8.62

Market Cap

110.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPLD
XGN
Founded
2010
2002
Country
United States
United States
Employees
760
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
110.7M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
UPLD
XGN
Price
$3.57
$8.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.75
$8.86
AVG Volume (30 Days)
29.3K
219.5K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
63.38
N/A
EPS
N/A
N/A
Revenue
$74,767,000.00
N/A
Revenue This Year
N/A
$8.12
Revenue Next Year
$1.95
$13.00
P/E Ratio
N/A
N/A
Revenue Growth
6.95
N/A
52 Week Low
$0.50
$2.59
52 Week High
$6.65
$12.23

Technical Indicators

Market Signals
Indicator
UPLD
XGN
Relative Strength Index (RSI) 42.73 73.81
Support Level $0.62 $4.08
Resistance Level $5.65 N/A
Average True Range (ATR) 0.37 0.39
MACD 0.00 0.05
Stochastic Oscillator 39.04 96.79

Price Performance

Historical Comparison
UPLD
XGN

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: